Graham Juan's Form 4 filing
Kyntra Bio, Inc.KYNB · filed Dec 14, 2022
- Accession no.
- 0001209191-22-061328
- Filed
- Dec 14, 2022
- Trade date
- Dec 9-12, 2022
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $32.0K. It was filed 5 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001209191-22-061485 (Dec 15, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Graham JuanCIK 0001879223 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2022 | Common Stock | SSaleDisposed | −781 | $14.90 | −$11,636.9 | 55,110 | Direct | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −1,407 | $14.50 | −$20,401.5 | 53,703 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.